“While recent single-cell multiomics studies and CRISPR screens in murine NK cells have expanded our understanding, actionable genomic targets in primary human NK cells have remained largely ...

From the moment they’re born, newborns — or, specifically, their immune systems — must learn to fight germs without harming their own tissues. In a new study, Yale researchers found that one type of ...

Van Andel Institute scientists and collaborators have discovered a potential treatment target that may re-energize dysfunctional or "exhausted" immune cells in their fight against cancer. The target ...

Scientists at UCL have engineered a rare type of immune cell to kill slow-growing bowel cancer cells that are resistant to current therapies, a breakthrough that could lead to new treatments in the ...